Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cell Death Differ ; 15(9): 1396-407, 2008 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-18437160

RESUMO

The RNA alphavirus Semliki Forest (SFV) triggers apoptosis in various mammalian cells, but it has remained controversial at what infection stage and by which signalling pathways host cells are killed. Both RNA synthesis-dependent and -independent initiation processes and mitochondrial as well as death receptor signalling pathways have been implicated. Here, we show that SFV-induced apoptosis is initiated at the level of RNA replication or thereafter. Moreover, by expressing antiapoptotic genes from recombinant SFV (replicons) and by using neutralizing reagents and gene-knockout cells, we provide clear evidence that SFV does not require CD95L-, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)- or tumor necrosis factor-mediated signalling but mitochondrial Bak to trigger cytochrome c release, the fall in the mitochondrial membrane potential, apoptotic protease-activating factor-1/caspase-9 apoptosome formation and caspase-3/-7 activation. Of seven BH3-only proteins tested, only Bid contributed to effective SFV-induced apoptosis. However, caspase-8 activation and Bid cleavage occurred downstream of Bax/Bak, indicating that truncated Bid formation serves to amplify rather than trigger SFV-induced apoptosis. Our data show that SFV sequentially activates a mitochondrial, Bak-mediated, caspase-8-dependent and Bid-mediated death signalling pathway that can be accurately dissected with gene-knockout cells and SFV replicons carrying antiapoptotic genes.


Assuntos
Apoptose , RNA Viral/biossíntese , Vírus da Floresta de Semliki/genética , Proteína Killer-Antagonista Homóloga a bcl-2/metabolismo , Aedes/citologia , Animais , Proteínas Reguladoras de Apoptose/genética , Proteína Agonista de Morte Celular de Domínio Interatuante com BH3/fisiologia , Caspase 8/metabolismo , Caspases/metabolismo , Citocromos c/metabolismo , Genoma Viral , Mitocôndrias/metabolismo , Replicon , Transdução de Sinais , Proteína X Associada a bcl-2/metabolismo
2.
Cell Death Differ ; 14(6): 1172-80, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17396132

RESUMO

Cells exposed to sustained endoplasmic reticulum (ER) stress undergo programmed cell death and display features typical of apoptosis, such as cysteine aspartyl protease (caspase) activation, cytochrome c release, and DNA fragmentation. Here, we show that the execution of cell death induced by ER stress is mediated via the proteasome. Inhibition of the proteasome by lactacystin prevented ER stress-induced degradation of Bcl-2, release of cytochrome c, processing of effector caspase-3, and exposure of phosphatidylserine. Owing to the ability of lactacystin to inhibit cytochrome c release, we propose that the pro-apoptotic activity of the proteasome lies upstream of mitochondrial activation. Thus, the proteasome serves as a principal mediator of ER stress-induced cell death in this system.


Assuntos
Apoptose/fisiologia , Retículo Endoplasmático/metabolismo , Fibroblastos/metabolismo , Complexo de Endopeptidases do Proteassoma/metabolismo , Acetilcisteína/análogos & derivados , Acetilcisteína/farmacologia , Animais , Apoptose/efeitos dos fármacos , Western Blotting , Brefeldina A/farmacologia , Caspase 3/metabolismo , Células Cultivadas , Clorexidina/farmacologia , Citocromos c/metabolismo , Fragmentação do DNA/efeitos dos fármacos , Eletroforese em Gel de Poliacrilamida , Retículo Endoplasmático/efeitos dos fármacos , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Membranas Mitocondriais/metabolismo , Modelos Biológicos , Fosfatidilserinas/metabolismo , Inibidores de Proteassoma , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Ratos , Sulfonas/farmacologia , Temperatura , Enzimas Ativadoras de Ubiquitina/genética , Enzimas Ativadoras de Ubiquitina/metabolismo
3.
Cell Death Differ ; 10(10): 1188-203, 2003 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-14502242

RESUMO

Effective execution of apoptosis requires the activation of caspases. However, in many cases, broad-range caspase inhibitors such as Z-VAD.fmk do not inhibit cell death because death signaling continues via basal caspase activities or caspase-independent processes. Although death mediators acting under caspase-inhibiting conditions have been identified, it remains unknown whether they trigger a physiologically relevant cell death that shows typical signs of apoptosis, including phosphatidylserine (PS) exposure and the removal of apoptotic cells by phagocytosis. Here we show that cells treated with ER stress drugs or deprived of IL-3 still show hallmarks of apoptosis such as cell shrinkage, membrane blebbing, mitochondrial release of cytochrome c, PS exposure and phagocytosis in the presence of Z-VAD.fmk. Cotreatment of the stressed cells with Z-VAD.fmk and the serine protease inhibitor Pefabloc (AEBSF) inhibited all these events, indicating that serine proteases mediated the apoptosis-like cell death and phagocytosis under these conditions. The serine proteases were found to act upstream of an increase in mitochondrial membrane permeability as opposed to the serine protease Omi/HtrA2 which is released from mitochondria at a later stage. Thus, despite caspase inhibition or basal caspase activities, cells can still be phagocytosed and killed in an apoptosis-like fashion by a serine protease-mediated mechanism that damages the mitochondrial membrane.


Assuntos
Apoptose/fisiologia , Inibidores de Caspase , Fagocitose/fisiologia , Serina Endopeptidases/metabolismo , Clorometilcetonas de Aminoácidos/química , Clorometilcetonas de Aminoácidos/metabolismo , Clorometilcetonas de Aminoácidos/farmacologia , Animais , Anticorpos Monoclonais/farmacologia , Apoptose/efeitos dos fármacos , Western Blotting , Brefeldina A/farmacologia , Caspase 3 , Caspases/química , Caspases/metabolismo , Adesão Celular/efeitos dos fármacos , Adesão Celular/fisiologia , Linhagem Celular Tumoral , Cicloeximida/farmacologia , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/metabolismo , Citometria de Fluxo , Regulação da Expressão Gênica , Células HeLa , Humanos , Interleucina-3/deficiência , Interleucina-3/farmacologia , Camundongos , Microscopia de Fluorescência , Microscopia de Contraste de Fase , Modelos Biológicos , Fagocitose/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-bcl-2/genética , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/farmacologia , Ratos , Sulfonas/farmacologia , Tapsigargina/farmacologia , Tunicamicina/farmacologia , Células U937 , Receptor fas/imunologia
8.
Phys Rev A ; 50(1): 123-131, 1994 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-9910876
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA